Dexmedetomidine Vs Dexamethasone in Popliteal Nerve Block

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Ankle DiseaseAnkle Injuries and DisordersFoot InjuryFoot Diseases
Interventions
DRUG

0.9% Sodium chloride

administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the popliteal nerve block

DRUG

0.1mg/kg Dexamethasone

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the popliteal nerve block

DRUG

0.05ug/kg Dexmedetomidine

administration of 0.5ml/kg of 0.2% ropivacaine with 0.05ug/kg dexmedetomidine for the popliteal nerve block

Trial Locations (1)

61-545

RECRUITING

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER